-
February 28, 2022 100% of Psychonauts Visited Other Worlds During DMT StudyAnd 94% reported meeting with otherworldly beings during "profound and highly intense experiences."
-
February 24, 2022 LSD Microdosing Study Finds ‘No Residual Effects’ on Mood or CognitionAnother study concludes with results challenging the increasingly popular narrative that microdosing psychedelics improves mood...
-
February 23, 2022 4 Signs the Psychedelics Movement Is UnstoppableWith no strong resistance manifesting to oppose the psychedelic renaissance, it appears these drugs have...
-
February 22, 2022 Irwin Naturals’ Mission to Make Ketamine Therapy Affordable for the MassesThe revered wellness brand wields proven business savvy to innovate, disrupt and equalize through its...
-
February 21, 2022 How Long Until Psychedelic Stocks Payoff?Our resident Psychedelic Investor explores one of the biggest questions on minds of those investing...
-
February 18, 2022 ‘Altered States’: How One of Horror’s Most Psychedelic Films Altered My LifeFilmmaker Matthew Dunehoo, the director of our "Spotlight in Focus" series, reflects on a 1980...
-
February 18, 2022 Psychedelic Business Spotlight – February 18This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to...
-
February 17, 2022 Cybin Partners with The Chopra Foundation to Bring Awareness to the Benefits of Psychedelic-Based Therapies"The need for new and more effective treatments across the mental health spectrum is more...
-
February 16, 2022 Cathie Woods’ ARK Invest Conducting ‘Deep Dive’ Into Psychedelic StocksCathie Wood and Ark Invest buying psychedelic stocks will be significant for the industry, as...
-
February 16, 2022 5 Black Pioneers Combatting the Whitewashing of PsychedelicsThe uncomfortable irony of the psychedelic renaissance is that minorities are left out of the...
